Search Results - "Gibb, Fraser"
-
1
Risk of death following admission to a UK hospital with diabetic ketoacidosis
Published in Diabetologia (01-10-2016)“…Aims/hypothesis The aim of this study was to assess the risk of death during hospital admission for diabetic ketoacidosis (DKA) and, subsequently, following…”
Get full text
Journal Article -
2
Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes
Published in Diabetologia (01-08-2019)“…Aims/hypothesis Minimal evidence supports the efficacy of flash monitoring in lowering HbA 1c . We sought to assess the impact of introducing flash monitoring…”
Get full text
Journal Article -
3
575-P: Improvement in HbA1c after Flash Monitoring Is Not Associated with Risk of Retinopathy Progression in Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Background: Rapid improvement in HbA1c has been associated with significant short-term worsening of diabetic retinopathy. Flash monitoring (FM) is associated…”
Get full text
Journal Article -
4
UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy
Published in Diabetic medicine (01-07-2023)“…This best practice guide is written with the aim of providing an overview of current hybrid closed‐loop (HCL) systems in use within the United Kingdom's (UK)…”
Get full text
Journal Article -
5
-
6
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
Published in Diabetologia (01-05-2020)“…Aims/hypothesis We aimed to assess whether persistence of C-peptide secretion is associated with less glucose variability and fewer low-glucose events in…”
Get full text
Journal Article -
7
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation
Published in European journal of endocrinology (01-08-2020)“…The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are…”
Get full text
Journal Article -
8
Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism
Published in The journal of clinical endocrinology and metabolism (01-09-2019)“…Abstract Context Primary hyperparathyroidism (PHPT) has a prevalence of 0.86% and is associated with increased risk of nephrolithiasis and osteoporosis. PHPT…”
Get full text
Journal Article -
9
249-OR: Predictors of Impaired Awareness of Hypoglycemia in Adults with Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Background: Impaired awareness of hypoglycemia (IAH) is associated with a substantially increased risk of severe hypoglycemia (SH) in type 1 diabetes. Risk…”
Get full text
Journal Article -
10
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)
Published in European journal of endocrinology (01-02-2022)“…This European expert consensus statement provides recommendations for the diagnosis and management of primary hyperparathyroidism (PHPT), chronic…”
Get full text
Journal Article -
11
A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia
Published in PloS one (14-06-2024)“…Impaired awareness of hypoglycaemia (IAH) is a risk factor for severe hypoglycaemia (SH) in type 1 diabetes (T1D). Much of the IAH prevalence data comes from…”
Get full text
Journal Article -
12
Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic
Published in Journal of diabetes science and technology (01-03-2017)Get full text
Journal Article -
13
Outcomes after 1 year in adults using Omnipod 5: Real‐world data from a UK diabetes centre
Published in Diabetic medicine (01-12-2024)Get full text
Journal Article -
14
Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
Published in Diabetes, obesity & metabolism (01-07-2022)“…Aim To assess the efficacy, safety and tolerability of cotadutide in patients with type 2 diabetes mellitus and chronic kidney disease. Materials and Methods…”
Get full text
Journal Article -
15
Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis
Published in Clinical endocrinology (Oxford) (01-01-2019)“…Summary Objective Radioiodine (RAI) is an effective treatment for Graves’ thyrotoxicosis but is associated with a failure rate of 15% and may be a risk factor…”
Get full text
Journal Article -
16
Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2
Published in Diabetic medicine (01-11-2023)“…We sought to assess whether conversion from Freestyle Libre to Freestyle Libre 2 (with low and high glucose alert functions) was associated with improved…”
Get full text
Journal Article -
17
Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type 1 diabetes
Published in Diabetic medicine (01-07-2021)“…ABSTRACT Aims/hypothesis The aim of this study was to determine the impact of the routine use of serum C‐peptide in an out‐patient clinic setting on…”
Get full text
Journal Article -
18
Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors
Published in The journal of clinical endocrinology and metabolism (01-09-2019)“…Abstract Context Aromatase deficiency causes obesity and insulin resistance in aromatase knockout mice and humans with rare mutations of the aromatase gene…”
Get full text
Journal Article -
19
-
20
Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men
Published in The journal of clinical endocrinology and metabolism (01-05-2016)“…Context: Deficiency of aromatase, the enzyme that catalyzes the conversion of androgens to estrogens, is associated with insulin resistance in humans and mice…”
Get full text
Journal Article